Committee for Orphan Medicinal Products (COMP): 16-18 February 2021
Table of contents
Date:
16/02/2021 to 18/02/2021
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Agenda - COMP agenda of the 16-18 February 2021 meeting (PDF/272.24 KB)
Draft
First published: 16/02/2021
EMA/COMP/52622/2021 -
List item
COMP meeting report on the review of applications for orphan designation: February 2021 (PDF/160.23 KB)
First published: 01/03/2021
EMA/COMP/109507/2021 -
List item
Minutes of the COMP meeting 16-18 February 2021 (PDF/405.28 KB)
Adopted
First published: 03/05/2021
EMA/COMP/129196/2021